Cartwright Carrie - MD Anderson Cancer Center, The University of Texas

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 40 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Results of IMPACT 2, a Randomized Study Evaluating Molecular Profiling and Targeted Agents in Metastatic Cancer at MD Anderson Cancer Center

Apostolia Maria Tsimberidou,Siqing Fu,David S. Hong, Sarina A. Piha-Paul,Aung Naing, Jordi Rodon Ahnert,Timothy A. Yap,Daniel D. Karp, Ecaterina Elena Dumbrava, John Heymach,Jaffer A. Ajani,Carrie Cartwright,Jennifer Beck, Clark R. Andersen,Michael Kahle,David J. Vining, Jeffrey S. Ross, Calvin Y. Chao,Donald A. Berry, Funda Meric-Bernstam

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Phase 1 Trial Evaluating TTI-101, a First-in-class, Orally Bioavailable, Small Molecule, Inhibitor of STAT3, in Patients with Advanced Solid Tumors

Apostolia Maria Tsimberidou, David J. Vining, Sukeshi Patel Arora, Sofia de Achaval, Jeffrey Larson,Carrie Cartwright, Rony Avritscher, Imran Alibhai, Ahmed Omar Kaseb

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

Cited0Views0Bibtex

Supplementary Figures 1-3 from Oleandrin-mediated Inhibition of Human Tumor Cell Proliferation: Importance of Na,K-ATPase Α Subunits As Drug Targets

Peiying Yang,David G. Menter,Carrie Cartwright,Diana Chan,Susan Dixon,Milind Suraokar,Gabriela Mendoza,Norma Llansa,Robert A. Newman

openalex（2023）

Cited0Views0Bibtex

Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center

Henry Hiep Vo,Carrie Cartwright,I-Wen Song,Daniel D. Karp,Graciela M. Nogueras Gonzalez, Yuran Xie,Michael Karol,Matthew Hitron,David Vining,Apostolia-Maria Tsimberidou

Cancers（2022）

Cited11Views0WOSBibtex

Challenges and Opportunities Associated with the MD Anderson IMPACT2 Randomized Study in Precision Oncology

npj precision oncologyno. 1 (2022)

Cited4Views0WOSNATUREBibtex

Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors

Apostolia M. Tsimberidou,Philip A. Beer,Carrie A. Cartwright,Cara Haymaker,Henry H. Vo,Simin Kiany,Alexander R. L. Cecil,James Dow,Kemal Haque,Franck A. Silva, Lucy Coe, Helen Berryman,Elisabeth A. Bone,Graciela M. Nogueras-Gonzalez,David Vining,Hilary McElwaine-Johnn,Ignacio I. Wistuba

CLINICAL CANCER RESEARCH（2021）

Cited24Views0WOSBibtex

Long-term Overall Survival and Prognostic Score Predicting Survival: the IMPACT Study in Precision Medicine

Apostolia-Maria Tsimberidou,David S. Hong,Jennifer J. Wheler,Gerald S. Falchook,Filip Janku,Aung Naing,Siqing Fu,Sarina Piha-Paul,Carrie Cartwright,Russell R. Broaddus,Graciela M. Nogueras Gonzalez,Patrick Hwu,Razelle Kurzrock

Journal of hematology & oncology（2019）

Cited35Views0WOSBibtex

Precision Medicine: Clinical Outcomes Including Long-Term Survival According to the Pathway Targeted and Treatment Period–the IMPACT Study

Apostolia Maria Tsimberidou,David S. Hong,Jennifer J. Wheler,Gerald Steven Falchook,Aung Naing,Siqing Fu,Sarina Anne Piha-Paul,Filip Janku,Carrie Cartwright,Russell Broaddus, Graciela M. Nogueras-Gonzalez,Patrick Hwu, Razelle Kurzrock

Journal of Clinical Oncology（2018）

Cited18Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn